Literature DB >> 11874997

A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.

Peter A Gochee1, Lawrie W Powell, Digby J Cullen, Desiree Du Sart, Enrico Rossi, John K Olynyk.   

Abstract

BACKGROUND & AIMS: Two major mutations are defined within the hemochromatosis gene, HFE. Although the effects of the C282Y mutation have been well characterized, the effects of the H63D mutation remain unclear. We accessed a well-defined population in Busselton, Australia, and determined the frequency of the H63D mutation and its influence on total body iron stores.
METHODS: Serum transferrin saturation and ferritin levels were correlated with the H63D mutation in 2531 unrelated white subjects who did not possess the C282Y mutation.
RESULTS: Sixty-two subjects (2.1%) were homozygous for the H63D mutation, 711 (23.6%) were heterozygous, and 1758 (58.4%) were wild-type for the H63D mutation. Serum transferrin saturation was significantly increased in male and female H63D homozygotes and heterozygotes compared with wild-types. Serum ferritin levels within each gender were not influenced by H63D genotypes. Elevated transferrin saturation > or = 45% was observed in a greater proportion of male H63D carriers than male wild-types. Male H63D homozygotes (9%) and heterozygotes (3%) were more likely to have both elevated transferrin saturation and elevated ferritin > or = 300 ng/mL than male wild-types (0.7%). Homozygosity for H63D was not associated with the development of clinically significant iron overload.
CONCLUSIONS: Presence of the H63D mutation results in a significant increase in serum transferrin saturation but does not result in significant iron overload. In the absence of the C282Y mutation, the H63D mutation is not clinically significant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874997     DOI: 10.1016/s0016-5085(02)80116-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin.

Authors:  Jian Wang; Guohua Chen; Kostas Pantopoulos
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  External quality assurance of molecular analysis of haemochromatosis gene mutations.

Authors:  M Hertzberg; S Neville; D McDonald
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

3.  HFE gene mutations, serum ferritin level, transferrin saturation, and their clinical correlates in a Korean population.

Authors:  Sang Hyub Lee; Jin-Wook Kim; So Hyun Shin; Kyoung Phil Kang; Hyun Cheol Choi; Sung Hee Choi; Kyoung Un Park; Hyun Young Kim; Weechang Kang; Sook-Hyang Jeong
Journal:  Dig Dis Sci       Date:  2008-08-06       Impact factor: 3.199

4.  Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.

Authors:  Sophie G Zaloumis; Katrina J Allen; Nadine A Bertalli; Lidija Turkovic; Martin B Delatycki; Amanda J Nicoll; Christine E McLaren; Dallas R English; John L Hopper; Graham G Giles; Gregory J Anderson; John K Olynyk; Lawrie W Powell; Lyle C Gurrin
Journal:  J Gastroenterol Hepatol       Date:  2015-04       Impact factor: 4.029

5.  Fatty liver in H63D homozygotes with hyperferritinemia.

Authors:  Giada Sebastiani; Daniel F Wallace; Susan E Davies; Vasu Kulhalli; Ann P Walker; James S Dooley
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

6.  Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.

Authors:  V Boige; L Castéra; N de Roux; N Ganne-Carrié; B Ducot; G Pelletier; M Beaugrand; C Buffet
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

7.  The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis.

Authors:  B Z Alizadeh; O T Njajou; J M W Hazes; A Hofman; P E Slagboom; H A P Pols; C M van Duijn
Journal:  Ann Rheum Dis       Date:  2007-02-06       Impact factor: 19.103

8.  Compound heterozygote (C282Y/H63D) of hereditary hemochromatosis in a 16-year-old girl with hypoplastic kidney.

Authors:  Barbara Kaczorowska-Hac; Katarzyna Sikorska; Krzysztof P Bielawski; Krystyna Schramm; Anna Balcerska
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

Review 9.  Screening for hemochromatosis: patients with liver disease, families, and populations.

Authors:  Sumedha P Galhenage; Charlie H Viiala; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2004-02

10.  Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis.

Authors:  Shunji Tomatsu; Koji O Orii; Robert E Fleming; Christopher C Holden; Abdul Waheed; Robert S Britton; Monica A Gutierrez; Susana Velez-Castrillon; Bruce R Bacon; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.